Gustav K. von Schulthess
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Gustav K. von Schulthess has a total of 26 co-authors. Here are the top co-authors by number of shared publications:
- Patrick Veit-Haibach
University Hospital Zürich
3 shared publications - Gaspar Delso
GE Healthcare, Waukesha, WI USA
2 shared publications Patrick Veit-Haibach
Univ Zurich Hosp, Dept Med Radiol, CH-8091 Zurich, Switzerland
2 shared publications- Adrian Ciurea
Department of Rheumatology, University Hospital Zurich, University of Zurich, Zurich, Switzerland
1 shared publication - Andreas Boss
Institute of Diagnostic and Interventional Radiology, University Hospital Zurich, Raemistrasse 100, 8091 Zurich, Switzerland
1 shared publication - Beat A. Michel
Department of Rheumatology, Physical Medicine and Rehabilitation, University Hospital of Zurich, Zurich, Switzerland
1 shared publication
Latest Publications
- Open Access
- 21 July 2023
- Published by Springer Nature
- p. C3-C4
Correction to: Musculoskeletal Diseases 2021-2024
- 21 July 2023
- Published by Springer Nature
- p. C3-C4
Open AccessCorrection to: Musculoskeletal Diseases 2021-2024
- 1 May 2015
- Published by Elsevier in Seminars in Nuclear Medicine
- Vol. 45 (3) , 189-191
Guest Editorial
- 1 May 2015
- Published by Elsevier in Seminars in Nuclear Medicine
- Vol. 45 (3) , 189-191
Guest Editorial
- Open Access
- 23 December 2014
- Published by Springer Nature in EJNMMI Physics
- Vol. 1 (1) , 1-13
Clinical image quality perception and its relation to NECR measurements in PET
The purpose of this study is to describe a clinical relation of noise equivalent count rate (NECR) - an objective measurement of positron emission tomography (PET) systems - measured in a large number of patients, to clinical image quality of PET and their relation to 18F-fluoro-2-deoxyglucose (FDG) activity and patient's weight. A total of 71 consecutive patients were evaluated in this retrospective study. All data was automatically analysed using Matlab to estimate the noise equivalent count rate. Then, image quality was evaluated according to two subjective scores: the IQ local score was a 3-point scale assigned to each bed position in all patients and the IQ global score was a 10-point scale assigned after evaluating the coronal whole-body PET. Patient data was also analysed concerning weight, body mass index, FDG dose at the start of acquisition (D Acq), presence of bowel uptake and presence of FDG-positive pathologic lesions. Two additional parameters were defined for each patient: the ratio between D Acq and patient weight (R DW) and the ratio between D Acq and patient BMI (R DBMI). Clinically perceived image quality in PET has a significant positive correlation with NECR measured in patients, R DW, R DBMI and presence of pathologic lesions. Clinical image quality furthermore has significant negative correlation with weight, body mass index (BMI) and presence of bowel uptake. Thresholds of R DW and R DBMI in which clinical IQ is good to excellent in more than 90% of the patients were 2.6 and 8.0, respectively. Clinically perceived image quality in PET systems is positively and significantly related to NECR measured in patients. An optimal threshold for the R DW and R DBMI was defined in which clinical IQ is good to excellent in more than 90% of patients. With this data, it is possible to extrapolate technical as well as clinical image quality to other PET system and to predict clinical image perception.
- 23 December 2014
- Published by Springer Nature in EJNMMI Physics
- Vol. 1 (1) , 1-13
Open AccessClinical image quality perception and its relation to NECR measurements in PET
The purpose of this study is to describe a clinical relation of noise equivalent count rate (NECR) - an objective measurement of positron emission tomography (PET) systems - measured in a large number of patients, to clinical image quality of PET and their relation to 18F-fluoro-2-deoxyglucose (FDG) activity and patient's weight. A total of 71 consecutive patients were evaluated in this retrospective study. All data was automatically analysed using Matlab to estimate the noise equivalent count rate. Then, image quality was evaluated according to two subjective scores: the IQ local score was a 3-point scale assigned to each bed position in all patients and the IQ global score was a 10-point scale assigned after evaluating the coronal whole-body PET. Patient data was also analysed concerning weight, body mass index, FDG dose at the start of acquisition (D Acq), presence of bowel uptake and presence of FDG-positive pathologic lesions. Two additional parameters were defined for each patient: the ratio between D Acq and patient weight (R DW) and the ratio between D Acq and patient BMI (R DBMI). Clinically perceived image quality in PET has a significant positive correlation with NECR measured in patients, R DW, R DBMI and presence of pathologic lesions. Clinical image quality furthermore has significant negative correlation with weight, body mass index (BMI) and presence of bowel uptake. Thresholds of R DW and R DBMI in which clinical IQ is good to excellent in more than 90% of the patients were 2.6 and 8.0, respectively. Clinically perceived image quality in PET systems is positively and significantly related to NECR measured in patients. An optimal threshold for the R DW and R DBMI was defined in which clinical IQ is good to excellent in more than 90% of patients. With this data, it is possible to extrapolate technical as well as clinical image quality to other PET system and to predict clinical image perception.
- Open Access
- 20 December 2014
- Published by Springer Nature in EJNMMI Physics
- Vol. 1 (1) , 102
Metal artifact reduction in patients with dental implants using multispectral three-dimensional data acquisition for hybrid PET/MRI
Background: Hybrid positron emission tomography/magnetic resonance imaging (PET/MRI) shows high potential for patients with oropharyngeal cancer. Dental implants can cause substantial artifacts in the oral cavity impairing diagnostic accuracy. Therefore, we evaluated new MRI sequences with multi-acquisition variable-resonance image combination (MAVRIC SL) in comparison to conventional high-bandwidth techniques and in a second step showed the effect of artifact size on MRI-based attenuation correction (AC) with a simulation study. Methods: Twenty-five patients with dental implants prospectively underwent a trimodality PET/CT/MRI examination after informed consent was obtained under the approval of the local ethics committee. A conventional 3D gradient-echo sequence (LAVA-Flex) commonly used for MRI-based AC of PET (acquisition time of 14 s), a T1w fast spin-echo sequence with high bandwidth (acquisition time of 3.2 min), as well as MAVRIC SL sequence without and with increased phase acceleration (MAVRIC, acquisition time of 6 min; MAVRIC-fast, acquisition time of 3.5 min) were applied. The absolute and relative reduction of the signal void artifact was calculated for each implant and tested for statistical significance using the Wilcoxon signed-rank test. The effect of artifact size on PET AC was simulated in one case with a large tumor in the oral cavity. The relative difference of the maximum standardized uptake value (SUVmax) in the tumor was calculated for increasing artifact sizes centered over the second molar. Results: The absolute reduction of signal void from LAVA-Flex sequences to the T1-weighted fast spin-echo (FSE) sequences was 416 mm2 (range 4 to 2,010 mm2) to MAVRIC 481 mm2 (range 12 to 2,288 mm2) and to MAVRIC-fast 486 mm2 (range 39 to 2,209 mm2). The relative reduction in signal void was significantly improved for both MAVRIC and MAVRIC-fast compared to T1 FSE (−75%/− 78% vs. − 62%, p < 0.001 for both). The relative error for SUVmax was negligible for artifacts of 0.5-cm diameter (−0.1%), but substantial for artifacts of 5.2-cm diameter (−33%). Conclusions: MAVRIC-fast could become useful for artifact reduction in PET/MR for patients with dental implants. This might improve diagnostic accuracy especially for patients with tumors in the oropharynx and substantially improve accuracy of PET quantification.
- 20 December 2014
- Published by Springer Nature in EJNMMI Physics
- Vol. 1 (1) , 102
Open AccessMetal artifact reduction in patients with dental implants using multispectral three-dimensional data acquisition for hybrid PET/MRI
Background: Hybrid positron emission tomography/magnetic resonance imaging (PET/MRI) shows high potential for patients with oropharyngeal cancer. Dental implants can cause substantial artifacts in the oral cavity impairing diagnostic accuracy. Therefore, we evaluated new MRI sequences with multi-acquisition variable-resonance image combination (MAVRIC SL) in comparison to conventional high-bandwidth techniques and in a second step showed the effect of artifact size on MRI-based attenuation correction (AC) with a simulation study. Methods: Twenty-five patients with dental implants prospectively underwent a trimodality PET/CT/MRI examination after informed consent was obtained under the approval of the local ethics committee. A conventional 3D gradient-echo sequence (LAVA-Flex) commonly used for MRI-based AC of PET (acquisition time of 14 s), a T1w fast spin-echo sequence with high bandwidth (acquisition time of 3.2 min), as well as MAVRIC SL sequence without and with increased phase acceleration (MAVRIC, acquisition time of 6 min; MAVRIC-fast, acquisition time of 3.5 min) were applied. The absolute and relative reduction of the signal void artifact was calculated for each implant and tested for statistical significance using the Wilcoxon signed-rank test. The effect of artifact size on PET AC was simulated in one case with a large tumor in the oral cavity. The relative difference of the maximum standardized uptake value (SUVmax) in the tumor was calculated for increasing artifact sizes centered over the second molar. Results: The absolute reduction of signal void from LAVA-Flex sequences to the T1-weighted fast spin-echo (FSE) sequences was 416 mm2 (range 4 to 2,010 mm2) to MAVRIC 481 mm2 (range 12 to 2,288 mm2) and to MAVRIC-fast 486 mm2 (range 39 to 2,209 mm2). The relative reduction in signal void was significantly improved for both MAVRIC and MAVRIC-fast compared to T1 FSE (−75%/− 78% vs. − 62%, p < 0.001 for both). The relative error for SUVmax was negligible for artifacts of 0.5-cm diameter (−0.1%), but substantial for artifacts of 5.2-cm diameter (−33%). Conclusions: MAVRIC-fast could become useful for artifact reduction in PET/MR for patients with dental implants. This might improve diagnostic accuracy especially for patients with tumors in the oropharynx and substantially improve accuracy of PET quantification.
- 1 January 2013
- Published by Elsevier in Seminars in Nuclear Medicine
- Vol. 43 (1) , 3-10
Clinical Positron Emission Tomography/Magnetic Resonance Imaging Applications
- 1 January 2013
- Published by Elsevier in Seminars in Nuclear Medicine
- Vol. 43 (1) , 3-10
Clinical Positron Emission Tomography/Magnetic Resonance Imaging Applications
- Open Access
- 1 January 2012
- Published by Springer Nature in EJNMMI Research
- Vol. 2 (1) , 38
High bone turnover assessed by 18F-fluoride PET/CT in the spine and sacroiliac joints of patients with ankylosing spondylitis: comparison with inflammatory lesions detected by whole body MRI
This study compares the frequency and distribution of increased activity on 18 F-fluoride PET/CT with the presence of bone marrow edema on whole-body MR imaging in the spine and sacroiliac joints (SIJ) of patients with active ankylosing spondylitis (AS).
- 1 January 2012
- Published by Springer Nature in EJNMMI Research
- Vol. 2 (1) , 38
Open AccessHigh bone turnover assessed by 18F-fluoride PET/CT in the spine and sacroiliac joints of patients with ankylosing spondylitis: comparison with inflammatory lesions detected by whole body MRI
This study compares the frequency and distribution of increased activity on 18 F-fluoride PET/CT with the presence of bone marrow edema on whole-body MR imaging in the spine and sacroiliac joints (SIJ) of patients with active ankylosing spondylitis (AS).
- 23 December 2008
- Published by Springer Nature in European Journal of Nuclear Medicine and Molecular Imaging
- Vol. 36 (S1) , 3-9
A look ahead: PET/MR versus PET/CT
Integration of positron emission tomography (PET) and magnetic resonance (MR) has become a topic of increasing interest to the imaging community over the past two years. In this text, the authors attempt to distinguish facts from fiction concerning such integrated systems. Analysis of existing information of combined imaging on existing brain PET/MR systems and imaging experience with PET-computed tomography (CT) is reviewed. Various types of system integration of PET and MR are discussed with completely independent systems on one hand and completely integrated systems with the possibility of simultaneous data acquisition on the other hand. Furthermore, it is discussed, what simultaneous data acquisition with nuclear imaging systems combined with MR or CT really means, as technical simultaneity may not be relevant in light of the pharmacokinetics of the nuclear tracers used. The authors conclude that combining PET/MR is an interesting research endeavor with uncertain outcome. They argue that, while completely simultaneous brain applications are of research interest immediately, clinical applications do not currently warrant the construction of fully integrated systems. Systems adjacent to each other, where imaging tables are linked with a patient “shuttle” thereby requiring only patient translation but no repositioning, may be a good start to assess the value of integrated PET/MR.
- 23 December 2008
- Published by Springer Nature in European Journal of Nuclear Medicine and Molecular Imaging
- Vol. 36 (S1) , 3-9
A look ahead: PET/MR versus PET/CT
Integration of positron emission tomography (PET) and magnetic resonance (MR) has become a topic of increasing interest to the imaging community over the past two years. In this text, the authors attempt to distinguish facts from fiction concerning such integrated systems. Analysis of existing information of combined imaging on existing brain PET/MR systems and imaging experience with PET-computed tomography (CT) is reviewed. Various types of system integration of PET and MR are discussed with completely independent systems on one hand and completely integrated systems with the possibility of simultaneous data acquisition on the other hand. Furthermore, it is discussed, what simultaneous data acquisition with nuclear imaging systems combined with MR or CT really means, as technical simultaneity may not be relevant in light of the pharmacokinetics of the nuclear tracers used. The authors conclude that combining PET/MR is an interesting research endeavor with uncertain outcome. They argue that, while completely simultaneous brain applications are of research interest immediately, clinical applications do not currently warrant the construction of fully integrated systems. Systems adjacent to each other, where imaging tables are linked with a patient “shuttle” thereby requiring only patient translation but no repositioning, may be a good start to assess the value of integrated PET/MR.
- 1 April 2007
- Published by Elsevier in Médecine Nucléaire
- Vol. 31 (4) , 202-205
Quid des produits de contraste en TEP/TDM ?
- 1 April 2007
- Published by Elsevier in Médecine Nucléaire
- Vol. 31 (4) , 202-205
Quid des produits de contraste en TEP/TDM ?
- 1 November 2005
- Published by Springer Nature in European Radiology Supplements
- Vol. 15 (S4) , d121-d126
Integrated modality imaging with PET-CT and SPECT-CT: CT issues
The advantages of combining PET with CT are multiple and due to the anatomic referencing and the attenuation correction capabilities, which CT introduces, as well as a resulting increase in imaging speed and more efficient use of radiopharmaceuticals. These synergistic advantages are gained with combining PET-CT, but less so when combining SPECT-CT and almost not at all, when combining PET or SPECT with MR. PET-CT in oncology has firmly established itself as the best imaging modality in many settings of tumor staging and therapy monitoring. Whether the CT used in the combined imaging approach should be a full scale contrast enhanced CT or a low mAs unenhanced scan is currently a matter of debate. The use of contrast enhanced CT in PET-CT should be guided primarily by the availability of a prior recent enhanced CT-only scan and the diagnostic questions to be answered by the PET-CT examination and not by turf issues between nuclear physicians and radiologists. The future of combined imaging seems bright, as applications in SPECT-CT and in other disease entities are emerging.
- 1 November 2005
- Published by Springer Nature in European Radiology Supplements
- Vol. 15 (S4) , d121-d126
Integrated modality imaging with PET-CT and SPECT-CT: CT issues
The advantages of combining PET with CT are multiple and due to the anatomic referencing and the attenuation correction capabilities, which CT introduces, as well as a resulting increase in imaging speed and more efficient use of radiopharmaceuticals. These synergistic advantages are gained with combining PET-CT, but less so when combining SPECT-CT and almost not at all, when combining PET or SPECT with MR. PET-CT in oncology has firmly established itself as the best imaging modality in many settings of tumor staging and therapy monitoring. Whether the CT used in the combined imaging approach should be a full scale contrast enhanced CT or a low mAs unenhanced scan is currently a matter of debate. The use of contrast enhanced CT in PET-CT should be guided primarily by the availability of a prior recent enhanced CT-only scan and the diagnostic questions to be answered by the PET-CT examination and not by turf issues between nuclear physicians and radiologists. The future of combined imaging seems bright, as applications in SPECT-CT and in other disease entities are emerging.
- 1 August 2005
- Published by Hogrefe Publishing Group in Praxis
- Vol. 94 (35) , 1331-1337
Positronen Emissions Tomographie (PET) – Aktueller Stand und Ausblick
Die Anwendung der PET hat sich in den letzten Jahren stark entwickelt, wobei die mit Abstand am wichtigsten Indikationen Bildgebung von Tumoren betreffen. Insbesondere seit der Einführung der kombinierten PET-CT-Geräte ist abzusehen, dass sich PET zur Standardabklärung bei vielen Tumorleiden einerseits beim Staging und anderseits bei der Therapiekontrolle entwickelt. Dies ist darauf zurückzuführen, dass PET einen molekularen oder metabolischen Parameter, z.B. Zuckeraufnahme misst und nicht anatomische Veränderungen darstellt. Allerdings ist auch die anatomische Information oft für ein genaues Staging entscheidend: entsprechend setzt sich die PET-CT-Untersuchung rasch durch. In der Schweiz wurden im Jahr 2004 rund 8000 PET-Untersuchungen durchgeführt. Eine weitere Zunahme ist zu erwarten, man rechnet mit ca. 2000 bis 3000 notwendigen PET-Untersuchungen pro Million Einwohner und Jahr.Weitere Indikationen für PET liegen in der Hirn-, Herz- und Entzündungsdiagnostik mit erheblichem Wachstumspotential in allen drei Bereichen. Die nächste vielversprechende klinische Anwendung ist die integrierte PET-CT-Bildgebung des Herzens zur Darstellung der Anatomie der Herzkranzgefässe, gekoppelt mit der Quantifizierung der Herzperfusion in einen «cardiac one-stop-shop».
- 1 August 2005
- Published by Hogrefe Publishing Group in Praxis
- Vol. 94 (35) , 1331-1337
Positronen Emissions Tomographie (PET) – Aktueller Stand und Ausblick
Die Anwendung der PET hat sich in den letzten Jahren stark entwickelt, wobei die mit Abstand am wichtigsten Indikationen Bildgebung von Tumoren betreffen. Insbesondere seit der Einführung der kombinierten PET-CT-Geräte ist abzusehen, dass sich PET zur Standardabklärung bei vielen Tumorleiden einerseits beim Staging und anderseits bei der Therapiekontrolle entwickelt. Dies ist darauf zurückzuführen, dass PET einen molekularen oder metabolischen Parameter, z.B. Zuckeraufnahme misst und nicht anatomische Veränderungen darstellt. Allerdings ist auch die anatomische Information oft für ein genaues Staging entscheidend: entsprechend setzt sich die PET-CT-Untersuchung rasch durch. In der Schweiz wurden im Jahr 2004 rund 8000 PET-Untersuchungen durchgeführt. Eine weitere Zunahme ist zu erwarten, man rechnet mit ca. 2000 bis 3000 notwendigen PET-Untersuchungen pro Million Einwohner und Jahr.Weitere Indikationen für PET liegen in der Hirn-, Herz- und Entzündungsdiagnostik mit erheblichem Wachstumspotential in allen drei Bereichen. Die nächste vielversprechende klinische Anwendung ist die integrierte PET-CT-Bildgebung des Herzens zur Darstellung der Anatomie der Herzkranzgefässe, gekoppelt mit der Quantifizierung der Herzperfusion in einen «cardiac one-stop-shop».